Drugs Market Research Reports & Industry Analysis

... Sprays Others Market Segment by Applications, can be divided into Asthma COPD Allergic Rhinitis Other There are 19 Chapters to deeply display the Asia-Pacific Inhalation & Nasal Spray Generic Drugs market. Chapter 1, to describe Inhalation & Nasal Spray Generic Drugs Introduction, product type and application ...

... focuses on the Cancer Treatment Drugs in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Sciences Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

... Sprays Others Market Segment by Applications, can be divided into Asthma COPD Allergic Rhinitis Other There are 15 Chapters to deeply display the global Inhalation & Nasal Spray Generic Drugs market. Chapter 1, to describe Inhalation & Nasal Spray Generic Drugs Introduction, product scope, market overview ...

... Europe Cancer Treatment Drugs market. Chapter 1, to describe Cancer Treatment Drugs Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Cancer Treatment Drugs ...

... Market Segment by Applications, can be divided into Tablet Drug Granules Drug Oral Solution Others There are 17 Chapters to deeply display the Europe Paracetamol market. Chapter 1, to describe Paracetamol Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Paracetamol ...

... the factors favouring market growth. However, off- patented drugs, postoperative bleeding and availability of generic antithrombotic drugs would restrict the antithrombotic drugs market growth. Furthermore, new product launches by key vendors, up-gradation in the antithrombotic drugs and ...

... had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market. HIV antivirals segment among ...

... drugs and rising threats from thrombosis and PRCA are the factors inhibiting the market size. By Application, anemia segment leads the Erythropoietin Drugs market during the forecast period. On the other hand, retail pharmacies in end user segment dominated the global market with a huge market ...

... Sprays Others Market Segment by Applications, can be divided into Asthma COPD Allergic Rhinitis Other There are 18 Chapters to deeply display the China Inhalation & Nasal Spray Generic Drugs market. Chapter 1, to describe Inhalation & Nasal Spray Generic Drugs Introduction, product type and application ...

... Sprays Others Market Segment by Applications, can be divided into Asthma COPD Allergic Rhinitis Other There are 17 Chapters to deeply display the Europe Inhalation & Nasal Spray Generic Drugs market. Chapter 1, to describe Inhalation & Nasal Spray Generic Drugs Introduction, product type and application ...

... increase in China. According to statistics of ASKCI, in 2015, total output of antineoplastic drugs was about 440 tonnes, with the market scale of ... the strategy of sales in a wide range. In 2021, the forecast of China antineoplastic drug market will reach more than RMB250 billion, relatively conservative ...

... , Merck and Pfizer. This report segments the global oral antidiabetic drugs Market as follows: Global Oral Antidiabetic Drugs Market: Drugs Class Analysis Sulfonylureas Glimepiride Gliclazide Glyburide Others Meglitinides ...

... display the global Neuromyelitis Optica Drug market. Chapter 1, to describe Neuromyelitis Optica Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Neuromyelitis Optica Drug, with ...

Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company The competitive intelligence report „Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company“ evaluates and describes the competitive landscape of antibody-drug conjugates ... -specific R&D pipelines of ADCs. Competitor projects are listed in a tabular format providing information on: Drug Codes, Target/Mechanism of Action, Class of Compound (antibody, linker, payload ...

... rare disease treatments by enhancing their pipelines or by acquiring promising molecules of smaller companies. While the orphan drug market is mostly restricted to the U.S. and Europe ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ... , such as specimen preparation devices, controls, calibrators and others. “2015 France Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Competitive Strategies, Country Volume and ...

The 2017 U.S. All other merchandise sold through Pharmacies & drug stores-Product & Retail Report, published ... features 2017 current and 2018 forecast estimates on the sales of Seasonal decorations sold through Pharmacies & drug stores nationally and for all 50 U.S. States ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores-Product & Retail Report, ... 2017 current and 2018 forecast estimates on the sales of Drugs, health aids, beauty aids sold through Beer, wine, & liquor stores nationally and for all 50 U.S. States ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores-Product & Retail ... estimates on the sales of Drugs, health aids, beauty aids sold through Gasoline stations with convenience stores nationally and for all 50 U.S. States and up to 900 metro ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Pharmacies & drug stores-Product & Retail Report, published annually by Barnes Reports, contains ... features 2017 current and 2018 forecast estimates on the sales of Drugs, health aids, beauty aids sold through Pharmacies & drug stores nationally and for all 50 U.S. States and ...

The 2017 U.S. Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids sold through Supermarkets & other grocery (except convenience) stores nationally and for all 50 U.S. States and up to 900 ...

The 2017 U.S. Drugs, health aids, beauty aids, including cosmetics sold through Gift, novelty, & souvenir stores-Product & ... estimates on the sales of Drugs, health aids, beauty aids, including cosmetics sold through Gift, novelty, & souvenir stores nationally and for all 50 U.S. States and up to 900 ...

... Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing's proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project ... a 1-year online access to the data of the R&D Drug Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase. Benefits from the R&D Drug Pipeline Database ...

Anti-CD22 Immunotherapeutics in: October 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf ... Pipeline: Anti-CD22 Immunotherapeutics CD-22Targeted Immunotherapeutics include: Naked Antibodies & Combinations Radioimmunotherapeutics Immunotoxins Antibody-Drug Conjugates Autologous CAR T-Cells Information about the anti-CD22 Immunotherapeutics pipeline ...

... : BCMA-Targeted Antibodies & T-Cellls BCMA-Targeted Antibodies & T-Cells include: Autologous & allogeneic T-Cells Bispecific tumor-targeted antibodies & T-cells Bispecific T-Cell and NK-Cell redirecting antibodies Antibody-Drug Conjugates Information about the BCMA-Targeted Antibodies & T-Cells pipeline ...

BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information about Bispecific Antibodies released during the month of October 2016 ... Tracker for Bispecific Antibodies. Featured presentations of October 2016 include the pipeline of B-Cell Maturation Antigen (BCMA)-targeted immunotherapeutics, the profile of German technology company Pieris ...

... Tumor Necrosis Factor Inhibitors Approaches Used in Development of Anti-TNF TNF Inhibitors Market Overview Tumor Necrosis Factor as an Anti-Cancer Agent Global Tumor Necrosis Factor Inhibitors Pipeline by Company, Indication & Phase Global Tumor Necrosis Factor Inhibitors Pipeline: 151 Marketed Tumor Necrosis ...

... display the global Specialty Drug Distribution market. Chapter 1, to describe Specialty Drug Distribution Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Specialty Drug Distribution, with ...

The Global Parkinsons Disease Drug Industry Analysis & Forecast Market Report 2016-2021 is a professional and in-depth study on the current state of the Parkinsons Disease Drug industry. The report analysis the global market of Parkinsons Disease Drug by main manufactures and geographic regions. The report includes Parkinsons Disease Drug definitions, classifications ...

Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of September 2016. This ... for Antibody-Drug Conjugates. Featured presentations of September 2016 include the pipeline of Her2-targeted antibody-drug conjugates, the profile of Swiss biotech NBE Therapeutics and the profile of anti-Her2 antibody-drug conjugate MEDI4276 ...

... -2021), Global Anemia Drugs market is projected to exhibit a CAGR of over ~9.05% during 2016 - 2021. On the basis of market segment, Global Anemia Drugs Market has been segmented by Type (Iron Deficiency Anemia, Chronic Kidney ...

... contracting, and higher proof of value. Orphan drug developers need to take seriously the issues payers face and Orphan Drug Market Access: Payer Insights is a “must read” report that shows how positively working with them will have real market access benefits ...

According to Stratistics MRC, the Global Drug Discovery Technologies market is estimated at $XX million in 2015 and is expected to reach $XX million by 2022 ... and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease ...

... Endoscopic Sinus Surgery (FESS) and Balloon Sinus Dilation (BSD). Intersect, is the only company that has developed drug releasing bio-absorbable implants (drug eluting sinus stents- DESS) that enable targeted and sustained release of therapeutic agents, increasing the effectiveness of the sinus ...

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 ... and R&D. Quick drug approvals is also a major factor helping the regional growth. Some of the key players of the Immunotherapy Drugs market include Aduro BioTech ...

... to increase as orphan drug price continue to rise. How can industry proactively respond to demonstrate value and support pricing? Clinical trials: As the orphan drug market ... full potential of the orphan drug market Key Topics Explored The drivers of pharma and investor interest in the potential of orphan drugs are demonstrated, as the ...

“Pancreatic Beta-cell Protection Hot Targets & Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of Pancreatic Beta-cell protection. The report covers hot targets & molecules ...

The Europe Pulmonary Drug Delivery Systems Industry Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the Pulmonary Drug Delivery Systems Industry. The report ... , applications and industry chain structure. The Pulmonary Drug Delivery Systems Industry analysis is provided for the Europe markets including development trends, competitive landscape analysis ...

Renub Research report titled “Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast” provides a comprehensive analysis of the current state of the market and likely future evolution ...

... This report segments the drug discovery informatics market as follows: Drug Discovery Informatics Market: Mode Segment Analysis Outsourced Informatics In-House Informatics Drug Discovery Informatics Market: Services Segment Analysis Docking Modular Modeling Drug Discovery Informatics Market: Regional Segment ...

... Global Respiratory Drugs and Devices Market is expected to grow at a CAGR of 8% for the forecasted period of 2015-2020. Respiratory drugs market has 65% market share compared to 35% market share of respiratory devices ...

Market access for orphan drugs: Can your company break through in emerging markets? Find out which emerging markets offer the best investment prospects for orphan drug ... America Market Access Director, Leading Orphan Drug Company International Marketing Director, Europe-based orphan drug manufacturer Market Access Director, Rare Cancers-focused Biopharmaceutical Company Orphan Disease ...

... strategy and build a more compelling case for specialty drugs with FirstWord’s new report, The Cost of Specialty Drugs: Payer Perspectives. Click here to view the ... in approaches to managing specialty drug costs and the challenges faced by payers today. Read it to understand how the market is responding to rapidly rising specialty drug costs – and assess ...

... report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...

This new 300-page report from VPGMarketResearch.com provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.

Global drug discovery informatics market is anticipated to reach USD 6,548.1 million by 2022, according to a new ... drive the adoption of in-silicotherapeutic product discovery models thus, influencing sectorprogress over the forecast period. Drug discovery informatics industry is estimated to witness lucrative ...

... is no way the body can produce iron itself. Intravenous (IV) treatment, in a broad sense, ... the first generation drugs InFed (iron dextran) and Dexeferrum (iron dextra) and feraccru ... global iron products industry along with an extensive coverage of global, Europe and the US I.V. iron market. The global IV iron ...

... made. 1.INTRODUCTION In this report, ASKCI analyzes the financial assessment and credit risk of veterinary drug industry. It will provide you ... understanding of financial situation and credit risk on China’s veterinary drug industry; To understand position of the veterinary drug industry in China; To get more ...

... into the market for generic drugs in Japan. Key Questions Answered: What are generic drugs? How are they different from branded drugs? How has Japan’s generic drug market performed in recent years? How have generic drugs ...

... market for obesity treatments should reach more than $7.8 billion by 2021 from over $4.3 billion in 2016 increasing at a compound annual growth rate ... surgeries market should reach over $4.3 billion by 2021 from almost $3.4 billion in 2016, at a CAGR of 5.0% from 2016 to 2021. The FDA-approved drugs market ...